Skip to main content
. 2024 Jan 3;10:5. doi: 10.1038/s41531-023-00617-7

Table 1.

Demographics and clinical characteristics of PD + pRBD, PD-pRBD and HC groups.

PD+pRBD (n = 36) PD-pRBD (n = 57) HC (n = 71) P-value
Age, mean ± SD, yearsa 61.2 ± 6.5 58.4 ± 8.8 60.5 ± 8.3 0.202
Sex, male, n (%)b 19 (52.8) 26 (45.6) 32 (45.1) 0.729
Education level, median ± IQR, yearsc 11.0 ± 5.0 9.0 ± 6.0 12.0 ± 6.0 0.182
Age at onset, mean ± SD, yearsd 57.5 ± 7.3 55.5 ± 9.1 NA 0.329
Disease duration, median ± IQR, yearse 3.0 ± 3.0 2.0 ± 2.5 NA 0.161
MDS-UPDSR, mean ± SDd 43.1 ± 16.7 35.9 ± 15.9 NA 0.039f
MDS-UPDRS part I, median ± IQRe 9.0 ± 6.0 5.0 ± 5.0 NA <0.001f
MDS-UPDRS part II, median ± IQRe 9.0 ± 7.7 7.0 ± 8.0 NA 0.321
MDS-UPDRS part III, median ± IQRe 24.5 ± 18 23.0 ± 15.5 NA 0.220
H&Y stage, n, 1/2/2.5b 7/23/1 23/26/2 NA 0.067
MoCA, median ± IQRc 24.0 ± 3.7 26.0 ± 4.0 26.0 ± 4.0 <0.001f,g
HAMD-17, median ± IQRc 8.0 ± 7.7 4.0 ± 4.0 1.0 ± 4.0 <0.001f,g,h
RBDQ-HK, median ± IQRc 28.5 ± 14.5 3.5 ± 8.7 7.0 ± 9.0 <0.001f,g
ESS, median ± IQRc 4.0 ± 4.0 3.0 ± 4.0 4.0 ± 3.0 0.464
PSQI, median ± IQRc 8.0 ± 6.0 3.0 ± 4.0 4.0 ± 5.0 0.008f,g
AS, median ± IQRc 10.0 ± 17.0 6.0 ± 14.0 4.0 ± 10.0 0.066
B-SIT, median ± IQRc 7.0 ± 4.0 8.0 ± 3.5 10.0 ± 3.0 <0.001g,h

RBD Rapid Eye Movement Sleep Behavior Disorder, pRBD probable RBD, PD + pRBD PD with probable RBD, PD-pRBD PD without probable RBD, HC healthy control, MDS-UPDRS Movement Disorder Society Unified Parkinson’s Disease Rating Scale, MDS-UPDRS part I Non-motor Aspects of Experiences of Daily Living section of MDS-UPDRS, MDS-UPDRS part II Motor Aspects of Experiences of Daily Living section of MDS-UPDRS, MDS-UPDRS part III Motor Examination section of MDS-UPDRS, H&Y Hohen & Yahr scale, MoCA Montreal Cognitive Assessment, HAMD Hamilton Depression scale, RBDQ-HK, RBD Questionnaire-Hong Kong version, ESS Epworth Sleepiness Scale, PSQI Pittsburgh Sleep Quality Index, AS Apathy Scale, B-SIT Brief Smell Identification Test, SD standard deviation.

P values with statistically significant differences are highlighted in bold text.

aAnalysis of variance (ANOVA) followed by post hoc test corrected by Bonferroni was used.

bThe Χ2 was used.

cKruskal-Wallis H-test followed by post hoc test corrected by Bonferroni was used.

dVariables with mean ± SD compared via independent t-test.

eVariables with median ± IQR compared via Mann-Whitney U test.

fComparison between PD+pRBD group and PD-pRBD group.

gComparison between PD+pRBD group and healthy control group.

hComparison between PD-pRBD group and healthy control group.